Niccolò Bitto/LinkedIn
Apr 10, 2026, 15:54
Niccolò Bitto: Answers to Some of the Most Frequently Asked Questions on Gene Therapy for Hemophilia
Niccolò Bitto, Internist at the Policlinic Hospital in Milan, shared on LinkedIn about a recent article he and his colleagues co-authored, adding:
”An educational review that answers some of the most frequently asked questions on gene therapy for hemophilia, with a practical approach.
In particular, we shared our experience regarding hepatological management before and after this innovative therapy.
Thanks to Prof. Wolfgang Miesbach and Dr. Hoffmann”
Title: Overview of gene therapy for hemophilia: questions and answers to navigate the innovation
Authors: Pascal Hoffmann, Niccolò Bitto, Vincenzo La Mura, Wolfgang Miesbach
Read the Full Article on JTH
Stay updated on all scientific advances with Hemostasis Today.
-
Apr 10, 2026, 15:52Tareq Abadl: Coombs Test Explained in a Simple and Clear Way
-
Apr 10, 2026, 15:10Jecko Thachil: Should We Consider Air Pollution as a Thrombophilic Marker?
-
Apr 10, 2026, 14:02Pablo Corral: Are Cholesterol and Inflammation Really Equal in Atherosclerosis?
-
Apr 10, 2026, 13:43Mohammed Alo։ How Low Should LDL Go in Secondary Prevention of Cardiovascular Disease
-
Apr 10, 2026, 13:21John Abraham: Telomere Biology Disorders – From Bench to Bedside
-
Apr 10, 2026, 01:19Heghine Khachatryan: When Vascular Fragility Defines Risk – Rethinking Hemostasis in LDS
-
Apr 9, 2026, 21:39Mechanisms of Immune Dysregulation in Immune Thrombocytopenia – JTH
-
Apr 9, 2026, 21:37Arun V J: The Nation Inside the Human Body and Blood Function
-
Apr 9, 2026, 21:36José Antonio García Erce: Fall of While Blood Donation And Apheresis Growth in Spain